1. Home
  2. MXE vs BYSI Comparison

MXE vs BYSI Comparison

Compare MXE & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Equity and Income Fund Inc. (The)

MXE

Mexico Equity and Income Fund Inc. (The)

N/A

Current Price

$13.42

Market Cap

57.9M

Sector

Finance

ML Signal

N/A

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$1.57

Market Cap

58.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MXE
BYSI
Founded
1990
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.9M
58.4M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
MXE
BYSI
Price
$13.42
$1.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2K
22.4K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.05
$1.18
52 Week High
$14.30
$3.44

Technical Indicators

Market Signals
Indicator
MXE
BYSI
Relative Strength Index (RSI) 50.53 51.80
Support Level $12.80 $1.56
Resistance Level $14.17 $1.83
Average True Range (ATR) 0.32 0.13
MACD -0.05 0.00
Stochastic Oscillator 70.10 61.76

Price Performance

Historical Comparison
MXE
BYSI

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: